vimarsana.com
Home
Live Updates
CatalYm Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors : vimarsana.com
CatalYm Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors
CatalYmtoday announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation
Related Keywords
Australia ,
United States ,
Paris ,
France General ,
France ,
United Kingdom ,
Bayern Kapital ,
Sue Charles ,
Ciara Byrne ,
Catalym Gmb ,
Kostenloser Wertpapierhandel ,
Andreas Wallnoefer ,
Jonathan Tobin ,
Phil Lhuillier ,
Mana Communications ,
Trophic Communications ,
Novartis Venture Fund ,
Brandon Capital ,
Jeito Capital ,
Vesalius Biocapital ,
Biogeneration Ventures ,
Growth Differentiation ,
Phill Huillier ,
Chief Executive Officer ,
Ted Human Effector ,
Relocation Phase ,
Stephanie May ,
Charles Consultants ,
Catalym ,
Loses ,
Billion ,
Series ,
Financing ,
Xpand ,
Ccelerate ,
Hase ,
Linical ,
Development ,
Isugromab ,
Patients ,
Olid ,
Rumors ,
vimarsana.com © 2020. All Rights Reserved.